A Agilent Technologies, Inc.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.…
Industry Peers
Diagnostics & ResearchKey Statistics
About Agilent Technologies (NYSE: A)
›
Agilent Technologies (NYSE: A) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 18,200 employees.
The shares were at 170.02 USD on 20 November 2026, up 19.4% over 52 weeks. Its 52-week range is 108.35 USD to 182.93 USD: the price is 7.1% below the high and 56.9% above the low.
At a market capitalisation of 49.43B USD, it trades at 34.6 times trailing earnings and 26.1 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 34.6, so A is valued in line with them. It pays a dividend yielding 0.58% (it pays out 20% of its earnings), against a median of 0.77% among the dividend payers in that peer group.
Agilent Technologies reports return on equity of 19.3%, an operating margin of 24.5% and revenue up 8.1% year over year.
Its debt exceeds its cash by 2.39B USD, a debt-to-equity ratio of 0.50. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 20 analysts cover the stock, with an average rating of Buy; their mean price target of 183.14 USD is 7.7% above the current price. The next earnings report is expected on 23 November 2026.